The detection of kratom use through laboratory analysis is not a standard element in most routine drug screenings. Kratom contains compounds, primarily mitragynine, that are not typically targeted by common immunoassay or gas chromatography-mass spectrometry (GC-MS) tests used to identify substances like opioids, benzodiazepines, or amphetamines. Consequently, a standard drug panel will likely not reveal kratom consumption.
Specific testing for kratom is available, though its implementation is considerably less widespread. Such specialized testing often involves more sophisticated analytical techniques, such as high-performance liquid chromatography-mass spectrometry (HPLC-MS), which are capable of identifying and quantifying mitragynine and other kratom alkaloids. The application of these tests is generally limited to circumstances where there is a specific reason to suspect kratom use, or within research settings investigating its effects.